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Hyperglicemic induces pancreatic cells to produce inadequate insulin. However, previous studies revealed
that  soy protein induce pancreatic cells to secrete insulin. Hence, this study was aimed to investigate effect of soy
germed protein on the insulin and blood glucose level of type-2 diabetes mellitus with Zn enrichment. The
research involved twenty four women that characterized with having more blood glucose level than normal, body
mass index more than twenty three kg/m2, and age more than fourty years old. They were divided into three
groups randomly, eight woman for each group. The first, second and third group were treated respectively with
milk containing soy germed protein plus Zn, this product without Zn, and placebo, all for two months. Blood
samples were taken at baseline, one and two months after observation. Results showed that two months after
observation the insulin level increased from 194.79 to 519.82 pmol/ml (P = 0.033) in group consuming milk
containing soy germed protein with or without Zn, supported by significantly reduced blood glucose level. This
result might be correlated with the potency of isoflavones in soy germ protein to protect pancreatic beta cells
membrane from free radicals attack. Therefore, this  maintain the cells integrity and to secrete optimal insulin.
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INTRODUCTION
Hyperglicemic condition induces beta cells to produce
interleukine-1 beta and C-reactive protein (Larsen et al.
2007; Winarsi & Purwanto 2009), followed by lower cell
function  (Maedler et al. 2004; Welsh et al. 2005). It is
proved that inflammatory cytokine islet plays a role in
type-2 diabetes pathogenesis, with resulting in pancreatic
incapability to produce adequate insulin to compensate
insulin resistance condition.
Researchers reported that soy protein could control
blood glucose level (Hermansen et al. 2001; del Carmen
Crespillo et al. 2003) by inducing the pancreatic cells to
hypertrophi, and then influenced insulin secretion.
Winarsi et al. (2009) added that the protein content of soy
germed  was higher (42%) than soy non-germed  (36.5%).
The soy germed protein may be more potency on
pancreatic cell than soy non-germed. Daidzein and
glycitein were important isoflavone compounds in soy
germed  protein (Song et al. 2003; Winarsi et al. 2009). In
general soy isoflavone had been proved as antioxidant
and immunostimulator (Winarsi et al. 2005a,b). According
to that finding, the isoflavone of soy germed  play a role
to protect beta cells integrity and induces their action.
Winarsi et al. (2005a) also stated that woman above
40 years old had lower of Zn status. The Zn status
correlate with beta cells capabillity to secrete insulin.
Chausmer (1998) postulated that supplementation of Zn
could improve insulin sensitivity and suppress
complication diseases. Therefore, Zn is needed by type-2
diabetes patient. In this study, we investigated  the effect
of soy germed  protein milk enrich with Zn on the level of
plasma insulin and blood glucose of type-2 diabetes
patient.
MATERIALS  AND  METHODS
Subjects were 24 women from  Diabetic Clinic of the
Margono Soekarjo General Hospital, Purwokerto in 2009,
characterized by blood glucose in time level above normal
(> 200 mg/dl),  the Body Mass Index more than 23 kg/m2,
and the age of more than 40 years old, and live in
Purwokerto. All participants had to sign the informed
consent. All subjects were divided into three randomly
groups, each group consisted of eight women (Table 1).
First group was treated with milk containing soy germed
protein plus Zn, second group was given milk containing
soy germed protein without Zn, and third group was given
milk without soy germed  protein or Zn (placebo) (Table
2), for the period of two months with 25 g/d. Blood samples
were taken three times, at baseline, and  then continued
by 1 and 2 months after observation. As much as 3 ml
blood samples were collected in tubes with ethylene
diaminetetraacetic acids (EDTA), intravenously.
Part of the whole collected blood was analysed for
glucose level using Glucocard Tes Strip II. Blood was
centrifuged at 3000 rpm for 10 minutes. Subsequently two
different layers were formed; the above layer was the
plasma separated from the second layer (erythrocyte).
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Determining the Plasma Insulin Level. The insulin
level was determined using an Elisa Diagnostic
Automation, Inc. INSULIN Microplate ELISA Cat. No.
1606. Briefly, 25 µl plasma sample, controls and reference
were loaded into assigned wells. One hundred µl enzyme
was conjugated into each well and mixed for 5 seconds,
incubated for 30 minutes at 25 oC. Incubation mixture was
removed and the wells were rinsed five times with washing
buffer. One hundred µl solution buffer containing
hydrogen peroxide and the 100 µl tetramethylbenzidine
were dispensed into each well, then was incubated for
15 minutes at room temperature. The reaction was stoped
by 50 µl stop solution and the optical density was
determined at 450 nm with a microwell reader.
Determining Blood Glucose Level. Blood glucose level
was determined using an Glucocard Tes Strip II, GT-1620,
Arkray, Inc. 57 Nishi Aketa-CHO, Higashi-Kujo, Japan. A
drop of blood was collected by using a lancing device,
and was touch the blood to the tip of a test strip. The test
strip draw blood into the reaction chamber automatically,
and start the test meassure.
Statistical Analysis. Data collected were analyzed
statistically using Analysis of Varian (ANOVA).
RESULTS
Plasma Insulin Level of Type-2 Diabetes Mellitus.
At baseline time, the insulin range level was 249.68-
307.02 pmol/ml, that were not significantly different
between groups (P = 0.79). After 1 month of observation,
the insulin level was also not different (P = 0.34), but at
2 months after observation, the insulin level increased
from 194.79 to 519.82 pmol/ml (P = 0.033) in group
consuming milk containing soy germed protein plus Zn
(Figure 1), however it was not different with the consuming
milk containing soy germed protein without Zn (P = 0.08).
Blood Glucose Level of Type-2 Diabetes Mellitus. At
baseline time, the blood glucose range level was very high
i.e. 313-324.5 mg/dl, but was not significantly different
between groups (P = 0.98) as well as after 1 month
observation (P = 0.40). At two months after observation,
the blood glucose level decreased from 315.38 to 185.38 mg/dl
(P = 0.04) in group consuming milk containing soy germed
protein plus Zn, but not different with the milk containing
soy germed protein without Zn (P = 0.39).
DISCUSSION
Type 2 diabetes is characterized by impaired insulin
secretion and chronic insulin resistance. Soy germed
protein contains amino acids that can induce insulin
secretion more than soy non-germed protein, since soy
germed contain protein higher than the seed (Winarsi et
al. 2009). Four amino acids that are important to induce
insulin secretion, i.e. leucine, isoleucine, alanine and
arginine (Newsholme et al. 2006). Arginine dominate in
soy protein, followed by leucine, alanine, and isoleucine.
The arginine induces insulin secretion. The process
involves cation of amino acids transporter enter into beta
cells that leads membrane depolarization (Sener et al. 2000),
resulting an increase of Ca++ intracellular level.
Depolarization of membrane plasma induces activation of
voltage dependent calcium channels, as a result, increases
of Ca++ sitosolic and stimulates insulin secretion.
Furthermore, metabolism of L-arginine in beta cells
increases production of urea through the activity of
arginase or Nitric Oxide (NO) by Nitric oxide synthase
(NOS). In this case, inducible nitric oxide synthase (iNOS)
regulates cytokine proinflammatory existency (Ortis et al.
2006). Therefore, in that condition, consumption of L-
arginine and its metabolism have a negative effect on cell
function. This causes increase level of NO which
continuously suppresses insulin secretion, and may
correlates to mitochondrial role as coupling stimulation
of secretor.
Brosnan (2003) argues that arginine does not have
clinical effect. This amino acid quickly disappears in
epithelial intestine cells, because it is conversed to
ornithine and  citrulline, and then removed to kidney or
liver, and changed in to proline when it is secreted. Broca
Table 1. Characteristics (mean and SE) of type-2 diabetic women
at baseline
                                     A (n = 8)        B (n = 8)        C (n = 8)
Age (years)
BMI (kg/m2)
Blood glucose (mg/dl)
57.88 + 1.97
25.57 + 0.97
313 + 36.97
59 + 2.42
25.62 + 1.03
324 + 50.14
61.18 + 3.04
25.88 + 0.93
320 + 40.4
A = group consuming soy germed protein+Zn; B = group consuming
soy germed protein without Zn; C = group consuming placebo; n
= 8; mean + SEM.
Table 2. Chemical compositions (mean + SE) of supplement given
to subjects
                           Milk containing        Milk
                             soy germed     containing soy
                             protein+Zn    germed protein
Water (%)*
Ash (%)*
Fat(%)*
Protein (%)*
Carbohydrate (%)*
Total (%)
4.79 + 0.08
22.68 + 0.07
1.11 + 0.01
42 + 0.05
29.39 + 0.04
100 + 0.005
4.6 + 0.008
22.57 + 0.09
1.02 + 0.003
39.47 + 0.09
32.27 + 0.02
100 + 0.03
4.5 + 0.003
22.4 + 0.006
1.04 + 0.003
36.72 + 0.037
35.03 + 0.32
100 + 0.03
Placebo
*3 replications.
Figure 1. Insulin levels of type-2 diabetes.  soy germ protein+Zn,
 soy germ protein,  placebo.
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et al. (2003) assures that L-arginine is changed into L-
glutamate, and then stimulates insulin secretion. As an
insulin secretion stimullator, the role of L-glutamat is
debated. The molecullar mechanism may be to promote
insulin secretion. The intracellular role of L-glutamate on
insulin secretion is induced by nutrition. Causing of
glutamate role by insulin secretion amplificated pathway
was stimulated glucose (Maechler & Wollheim 1999).
During hyperglicemic period the level of cell glutamate
increases in islet of human, mouse and mice  (Rubi et al.
2001; Bertrand et al. 2002). The activated mitochondria
beta cells indirectly stimulates insulin exocytosis. It is
proven that glutamate could be transported into secretory
granull, and promote Ca++-dependent exocytosis (Hoy et
al. 2002). Glutamate role is initiated from the action of beta
cells expressing L-glutamate decarboxylase (GAD). GAD
overexpression reduces L-glutamate content in beta cells
islet (Rubi et al. 2001), and then suppreses the secretory
respons. The role of glutamate on insulin secretion remains
debatable.  Increase of intracellular glutamate level occured
with addition 16.7 mmol/L glucose in mouse islet, but the
insulin secretion was not observed (MacDonald & Fahien
2000). Incubation in 10 mmol/L L-glutamine increased
L-glutamate level 10 fold, but did not stimulate the insulin
secretion. Firstly, these findings confused Newsholmes
et al. (2006) about glutamate role. However, the other study
assured that incubation in glucose significantly improved
L-glutamate level in islet mouse and mice (Bertrand et al.
2002). Broca et al. (2003) against this glutamate hypotetic.
In their study, L-glutamine increased L-glutamate content,
but did not affect insulin secretion. However, the other
findings showed that activation of glutamate
dehydrogenase (GDH) lowers L-glutamate level, and in
this case insulin secretion increased. The debated explains
our finding that arginine which is more abundance in soy
germed protein stimulates beta cells to secrete insulin.
Kanetro et al. (2008) added that arginine and glycine amino
acids in soy germed protein regulates insulin hormone.
This soy compound has potency to lower the risk of
obesity and diabetes by improving insulin resistance
condition, and then regulates secretion of insulin from
beta cells pancreatic (Bhathena & Velasquez 2002).
Beside arginine, amino acid leucine was also reported
able to stimulate release of insulin by two different
mechanisms. First, leucine perform transamination into alfa
cetoisocaproic, subsequently mitochondrial oxidation.
Second, by activation of allosteric glutamate dehidrogenase
(GDH) that causes oxidation of glutamate to the
intermediate Krebs cycle, i.e. alfa ketoglutarate + ammonia.
This GDH influence explaines that secretion of insulin
which stimulated by leucine was inhibited by higher
glucose. Gao et al. (1999) added that glucose inhibited
leucine stimulation from glutaminolitic and secretion of
insulin in islet of isolated mice, by increasing ATP and
GTP intracellular, while ADP reduced and inhibited GDH
activities. The important role of GDH in secretion of insulin
was mediated by glucose and reversed action to catalyse
production  glutamate as an cofactor lead to exocytosis
insulin granull (Maechler & Wollheim 1999).
Regulation of insulin in type-2 diabetes after
consumption of milk containing soy germed protein might
be correlated with the potency of isoflavone as reported
by Winarsi et al. (2005b) that soy isoflavone improved
the cellular antioxidant protect cell membrane. This include
pancreatic beta cells membrane from free radicals attack,
hence the cells integrity can be maintained and secrete
optimal insulin.
The soy germed protein contain many isoflavones
antioxidant compounds. These compounds are different
between soy non germed protein and soy germed protein.
In soy non germed protein, the concentration of
isoflavones glycitein is very low, but high in the soy
germed  protein. However, currently lack of research
explore glycitein potency, while the isoflavone was
reported as the strongest radical scavenger (Hubert et al.
2008), hence is potential as beta cells membrane protector.
Zn metabolism disorder was also occured in type-2
diabetes and obesity subject. This condition resulted in
lowering Zn and antioxidant status (Winarsi et al. 2005b).
This condition disturb cells and stimulate disfunction of
endothelial cells that could cause other vascular diaseases.
Zn is cell structured compound (Winarsi et al. 2005b), so
that for the integrity of cell membrane Zn supplementation
is needed. However, our study showed that in group of
women patient consuming soy germed protein plus Zn
was not different with the one consuming soy germed
protein without Zn. It may be correlate with adequate Zn
status initial so that was sinergically improved integrity
of beta cell membrane, and then the function of cell is
better especially in secretion insulin. This potency was
supported by significantly reduced blood glucose level
from 315.38 into 185.38  mg/dl (P = 0.04) (Figure 2) in groups
consuming milk containing soy germed protein plus Zn
after 2 months of observation, although it was not different
in the without Zn group (P = 0.39). Simon and Taylor (2001)
reported that Zn supplementation attenuated
hyperglycemia in db/db mice. Thus, suggesting that the
Zn play role in pancreatic function and peripheral tissue
glucose uptake. Zn adequate supplementation may
improve in glycemic control and delay progression of
diabetes, showed less weight in group receiving soy
germed protein plus Zn compared with control groups. In
this research we use 280 ppm Zn for two month attenuated
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Figure 2. Blood glocose levels of type-2 diabetes.  soy germ
protein+Zn,  soy germ protein,  placebo.
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blood glucose, thus elevated insulin content of pancreatic
islets. This finding supported Bégin-Heick et al. (1985)
that Zn modulated high insulin secretory response of
pancreatic islets to glucose.
Based on this study result, the blood glucose level
was decreased for patient consumed soy milk enrich with
or without Zn, but not up to normal range. This might be
due to the impaired of beta cells function. Researchers
also reported that by increasing the age, show decreasing
affect of beta cell function as shown by the lowering
glucose tolerance in T2DM (Scheen et al. 1996; Samos &
Roos 1998). Glucose intolerance  due to ages was more
due to defect beta cells function compare to low cells
mass (Clark et al. 2001; Guiot et al. 2001).
Chronical hyperglicemic as the characteristic of T2DM
disturb beta cell pancreatic action, and cause impaired
secretion of insulin. These conditions affected regulation
of beta cells turnover (Donath & Halban 2004). Normal
blood glucose level was very important to be maintained.
Based on this study, the level of blood glucose was
significantly lower after two months of observation having
soy milk enrich with or without Zn. We found from this
study that consuming milk contain soy germed protein
for two months induces beta cell action to secrete insulin.
The level of insulin subject increased from 194.79 to
519.82 pmol/ml, supported by decrease of blood glucose
level from 315.38 to 185.38 mg/dl. For further research one
can study the time length consumption of soy milk enrich
with Zn to ensure the T2DM blood glucose patient able
to reach up to the normal level.
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